[1] Culjkovic B,Topisirovic I,Borden K L.Controlling gene expression through RNA regulons:the role of the eukaryotic translation initiation factor eIF4E[J].Cell Cycle,2007,6(1):65-69.
[2] 金锋,孙亮,王沥.核辅激活因子PGC-1 作用分子机制的研究进展[J].遗传,2005,27(2):302-308.
[3] Cunningham J T,Rodgers J T,Arlow D H,et al.mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex[J].Nature,2007,450(7170):736-740.
[4] Strimpakos A S,Karapanagiotou E M,Saif M W,et al.The role of mTOR in the management of solid tumors:An overview[J].Cancer Treatment Reviews,2009,35(2):148-159.
[5] Xiang H G,Hu Z Q,Wang W J,et al.Expression of phosphorylated mammalian target of rapamycin in colorectal cancer and it s significance[D].Acad J Sec Mil Med Univ,2009(30):517-520.
[6] Entrez Gene:Vascular endothelial growth factor A.
[7] Wang Y,Zhao Q,Ma S,et al.Sirolimus inhibits human pancreatic carcinoma cell proliferation by a mechanism linked to the targeting of mTOR/HIF-1 alpha/VEGF signaling[J].IUBMB Life.2007,59(11):717-721.
[8] Miyazawa M,Yasuda M,Fujita M,et al.Therapeutic strategy targeting the mTOR-HIF-1 alpha-VEGF pathway in ovarian clear cell adenocarcinoma[J].Pathology International.2009,59(1):19-27.
[9] Frost P,Shi Y,Hoang B,et al.AKT activity regulates the ability of mTOR inhibitors to prevent angiogenesis and VEGF expression in multiple myeloma cells[J].Oncogene,2007,26(16):2255-2262.
[10] Sabapathy K,Hochedlinger K,Nam SY,et al.Distinct roles for JNK1 and JNK2 in regulating JNK activity and C-Jun-dependent cell proliferation[J].Mol Cell,2004,15:713 725.
[11] Fraenkel M,Ketzinel-Gilad M,Ariav Y,et al.mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes[J].Diabetes,2008,57(4):945-957.
[12] 钟显飞,蒋明德.C-Jun氨基末端激酶信号转导通路在细胞凋亡中的作用[J].第四军医大学学报,2005,26(16):1533-1536.
[13] 杨晓静.猪骨骼肌生长及肌纤维类型分布的分子机理研究[D].南京:南京农业大学,2004.
[14] Le Bacquer O,Petroulakis E,Paglialunga S,et al.Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2[J].Journal of Clinical Investigation,2007,117(2):387-396.
[15] Wende A R,Huss J M,Schaeffer P J,et al.PGC-1alpha coactivates PDK4 gene expression via the orphan nuclear receptor ERRalpha:a mechanism for transcriptional control of muscle glucose metabolism[J].Mol Cell Biol,2005,25(24):10684-10694.
[16] Czubryt M P,McAnally J,Fishman G I,et al.Regulation of peroxisome proliferator-activated receptor gamma coactivator 1 alpha(PGC-1 alpha)and mitochondrial function by MEF2 and HDAC5[J].Proc Natl Acad Sci USA,2003,100(4):1711-1716.
[17] Yun K,Wold B.Skeletal muscle determination and differentiation:story of a core regulatory network and its context[J].Curr Opin Cell Biol,1996,8(6):877-889.
[18] 路文盛,程桦.PGC-1及其基因多态性与胰岛素抵抗[J].国际内分泌代谢杂志,2006,26(4):257-259.
[19] Brugarolas J B,Vazquez F,Reddy A,et al.TSC2 regulates VEGF through mTOR-dependent and -independent pathways[J].Cancer Cell,2003,4(2):147-158.
[20] 王红霞,张凤春,黄明主.MAPK信号转导通路在托瑞米芬非雌激素抗肿瘤中的作用[J].上海交通大学学报:医学版,2008,28(1):66-68.
[21] Hettinger K,Vikhanskaya F,Poh M K,et al.C-Jun promotes cellular survival by suppression of PTEN[J].Cell Death and Differentiation,2007,14:218-229. |